Independent UK insurance research · updated regularly Information only · not financial advice · disclosures in footer
Private Health (PMI) · cancer cover · 2026

Cancer cover in private health insurance: what’s included?

Cancer is where private cover earns its keep for a lot of people — fast diagnosis, a choice of consultant, and access to drugs the local NHS trust may not fund. But the depth of that cover swings hugely between a “core” plan and a “full” one, and the gap only shows up when you need to claim.

Typical private health insurance costs

Independent research — typical UK costs from ABI, Which? and MoneyHelper published data.

The short version

  • Full cancer cover pays for the whole journey — diagnosis, surgery, chemotherapy, radiotherapy and specialist drugs — usually with no time limit for as long as your consultant recommends treatment.
  • Core (or limited) cover handles diagnosis and often surgery, but caps or excludes radiotherapy, chemo and advanced drug therapies once you’re past that first stage.
  • The headline benefit is drug access: full policies typically fund NICE-approved licensed drugs even when your NHS trust won’t, and many cover licensed drugs still awaiting NICE approval.
  • The one thing no standard policy covers is a cancer you’d already been diagnosed with, or had symptoms of, before the policy started — that’s the pre-existing condition rule.

What each level of cancer cover typically includes

Stage of careFull cancer coverCore / limited cover
Diagnosis — consultations, scans, biopsiesCoveredUsually covered
Surgery to remove a tumourCoveredOften covered
Chemotherapy & radiotherapyCovered, no set time limitCapped by £ amount or time, or excluded
Targeted therapy & immunotherapyCovered where licensed and recommendedLimited or excluded
NICE-approved drugs your NHS trust won’t fundTypically coveredRarely covered
Palliative & end-of-life care, home nursingOften includedUsually not included

Indicative summary of how UK insurers structure cancer cover in 2026 — not a quote or a description of any one policy. Definitions, limits and drug lists vary by insurer, so always read the policy wording and any cancer-cover option before you buy.

What full cancer cover actually pays for

On a comprehensive policy with full cancer cover, the insurer follows you through the whole thing. It starts the moment your GP refers you with suspected cancer — the consultant appointment, the scans, the biopsy — and carries on through surgery, chemotherapy, radiotherapy and the specialist drugs your oncologist prescribes. Most full plans don’t put a clock or a hard cash ceiling on eligible active treatment; they keep paying for as long as your consultant says it’s clinically needed.

Around that core sit the things that make a diagnosis more bearable. Follow-up scans and monitoring, therapies to manage side effects, and on many policies a dedicated cancer nurse line you can call. Full cover from the larger insurers usually extends to palliative and end-of-life care, hospice fees and home nursing where that becomes the right path — the support that matters most when treatment moves from cure to comfort. For the diagnostic end of that journey, our page on MRI and scan cover explains how the imaging is funded.

Drugs, NICE and why the small print matters

If there’s one place where private cancer cover genuinely does something the NHS often can’t, it’s drug access. Full cover typically funds NICE-approved licensed cancer drugs even when your local NHS trust has decided not to pay for them — and many insurers run their own approved-drug lists that go further, covering licensed treatments that are still working through NICE, or ones NICE judged effective but too costly for the NHS. In practice that can mean starting a newer immunotherapy months earlier than you otherwise might.

There are edges to it, though. Drugs that are genuinely experimental, or not yet licensed in the UK, sit outside almost every policy. Some plans put a sub-limit on very long-term palliative care. And the difference between “full” and “core” isn’t marketing fluff — a core option might quietly cap radiotherapy at a fixed sum, which is fine until a long course of treatment runs past it. This is the part worth reading slowly, or asking an adviser to walk you through, before you assume you’re covered. How the rest of your plan is built — the excess you pay and whether treatment is outpatient or inpatient — shapes what a claim looks like too.

Pre-existing cancer: the line no policy crosses

This is the one to be clear-eyed about. Standard private medical insurance is designed for conditions that arise after you take the policy out. If you’ve already been diagnosed with cancer, or had symptoms you hadn’t yet seen a doctor about, that cancer — and treatment linked to it — won’t be covered. It’s the single most important exclusion in cancer cover, and it’s not something insurers bend on.

How your past health is handled depends on the underwriting. Moratorium underwriting looks back over recent years and can, in some cases, bring a previously treated condition back into cover after a clear spell — the mechanics are on our moratorium underwriting page. Full medical underwriting settles it up front instead. Either way, the honest position is that PMI protects you against the cancer you might get, not the one you already have. If you want the wider picture of what a policy funds day to day, the private health hub pulls the pieces together.

Cancer cover: FAQs

Almost all comprehensive UK policies include cancer cover of some kind — it’s a headline feature rather than an add-on you have to hunt for. What varies is the depth. Full cover runs from diagnosis through surgery, chemotherapy, radiotherapy and specialist drugs, usually with no time limit on eligible treatment. Core or limited cover deals with diagnosis and often surgery but caps or excludes the later, costlier stages. Check which one your plan actually offers before you assume the whole journey is paid for.
Full cover pays for eligible active treatment with no set time or, on most plans, no hard cash ceiling — the insurer keeps funding it for as long as your consultant recommends. Core (sometimes called limited) cover typically handles diagnosis and surgery, then caps radiotherapy, chemotherapy and advanced drugs at a fixed sum or time period, or leaves them out. The two can look similar on a summary page; the difference only bites during a long course of treatment, which is exactly when you need it not to.
Often, yes — and it’s one of the strongest arguments for private cover. Full cancer cover generally funds NICE-approved licensed drugs even when your local NHS trust has decided not to pay for them. Many insurers go further with their own approved-drug lists, covering licensed treatments still awaiting a NICE decision, or ones deemed effective but too expensive for the NHS. What stays out is anything experimental or not yet licensed in the UK. The exact list varies by insurer, so it’s worth checking theirs.
Not under a new standard policy. Private medical insurance covers conditions that arise after cover starts, so a cancer diagnosed — or showing symptoms — before the policy began is treated as pre-existing and excluded. With moratorium underwriting, a condition you’ve been clear of for a defined period can sometimes come back into cover, but that depends on the insurer’s terms and your own history. If a past diagnosis is in the picture, it’s a conversation to have with an adviser before you buy rather than after.
On full cancer cover from the larger insurers, usually yes — palliative care, hospice fees and home nursing are commonly included where treatment shifts from cure to comfort. Core cover often doesn’t stretch that far, and even some full plans put a sub-limit on very long-term palliative care. It’s an emotionally difficult thing to read about when you’re buying a policy, but it’s one of the more meaningful differences between plans, so it’s worth knowing where yours stands.
It depends on the insurer. Some build full cancer cover into their comprehensive plan by default; others treat it as an option or a tier you choose, with a cheaper core level as the entry point. Because it affects both the price and what you’re actually protected for, it’s one of the first things to pin down when you compare quotes — two policies at a similar monthly price can offer very different cancer cover underneath.
Full cancer cover costs more than a core option because it exposes the insurer to open-ended, expensive treatment — but for many people it’s the reason they hold a policy at all, so it’s rarely the first thing to trim. If the premium feels steep, the usual levers — a higher excess, a guided hospital list, dropping optional extras — tend to be better places to save than cutting back the cancer cover itself. Whether it’s worth it is a judgement only you can make for your own circumstances.

Information only — not financial advice. This page explains how cancer cover in UK private health insurance is generally structured to help you compare policies; it describes typical market practice, not the terms of any specific policy, and it is not a recommendation to buy, avoid or fund any cover or treatment. Always read the policy wording. My Insurance Expert is not an FCA-authorised intermediary and does not arrange or sell policies. Last updated: 2026-09-20